We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
-2.39%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$174M
AUM Growth
-$2.27M
Cap. Flow
+$10.4M
Cap. Flow %
6.01%
Top 10 Hldgs %
63.46%
Holding
237
New
6
Increased
44
Reduced
166
Closed
21

Top Buys

Rank Stock Value
1
CBUS icon
Cibus
CBUS
+$22.7M
2
BW icon
Babcock & Wilcox
BW
+$14.2M
3
CMA
Comerica
CMA
+$237K
4
PANW icon
Palo Alto Networks
PANW
+$207K
5
ZION icon
Zions Bancorporation
ZION
+$206K

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$12.6M
2
SSPY icon
Syntax Stratified LargeCap ETF
SSPY
+$2.72M
3
KYNB
Kyntra Bio
KYNB
+$1.59M
4
ADCT icon
ADC Therapeutics
ADCT
+$676K
5
SMDY
Syntax Stratified MidCap ETF
SMDY
+$341K

Sector Composition

Rank Sector Weight
1 Healthcare 25.28%
2 Industrials 9.63%
3 Technology 6.93%
4 Consumer Staples 6.52%
5 Consumer Discretionary 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QRVO icon
176
Qorvo
QRVO
$7.99B
$226K 0.13%
2,215
-162
-7% -$15.6K
ABBV icon
177
AbbVie
ABBV
$443B
$225K 0.13%
1,667
+67
+4% +$9.82K
ADP icon
178
Automatic Data Processing
ADP
$106B
$221K 0.13%
1,005
-56
-5% -$12.1K
REGN icon
179
Regeneron Pharmaceuticals
REGN
$78.5B
$221K 0.13%
307
-13
-4% -$10K
PAYX icon
180
Paychex
PAYX
$41.6B
$218K 0.13%
1,951
-150
-7% -$16.4K
QCOM icon
181
Qualcomm
QCOM
$155B
$217K 0.13%
1,827
-140
-7% -$16.1K
PFE icon
182
Pfizer
PFE
$143B
$217K 0.12%
5,906
-176
-3% -$6.85K
EXPE icon
183
Expedia Group
EXPE
$35.4B
$215K 0.12%
1,969
-333
-14% -$32.6K
GOOG icon
184
Alphabet (Google) Class C
GOOG
$4.36T
$214K 0.12%
1,767
-719
-29% -$83.2K
MCK icon
185
McKesson
MCK
$100B
$214K 0.12%
500
-105
-17% -$40.4K
CAH icon
186
Cardinal Health
CAH
$53.9B
$213K 0.12%
2,254
-604
-21% -$51K
GOOGL icon
187
Alphabet (Google) Class A
GOOGL
$4.36T
$212K 0.12%
1,775
-722
-29% -$83.1K
HSIC icon
188
Henry Schein
HSIC
$9.77B
$212K 0.12%
2,616
-28
-1% -$2.21K
LW icon
189
Lamb Weston
LW
$7.22B
$212K 0.12%
1,841
-396
-18% -$44.2K
BIIB icon
190
Biogen
BIIB
$30B
$211K 0.12%
742
-193
-21% -$57.5K
COR icon
191
Cencora
COR
$60.6B
$210K 0.12%
1,093
-267
-20% -$46.2K
CPB icon
192
Campbell Soup
CPB
$6.55B
$208K 0.12%
4,549
+392
+9% +$20.2K
CI icon
193
Cigna
CI
$73.8B
$208K 0.12%
+740
New +$193K
ITW icon
194
Illinois Tool Works
ITW
$82.6B
$207K 0.12%
826
-60
-7% -$14.1K
CAG icon
195
Conagra Brands
CAG
$6.94B
$206K 0.12%
6,097
-140
-2% -$5.05K
HON icon
196
Honeywell
HON
$77B
$205K 0.12%
1,049
-69
-6% -$12.8K
DOV icon
197
Dover
DOV
$27.6B
$205K 0.12%
1,389
-5
-0.4% -$715
CSCO icon
198
Cisco
CSCO
$457B
$204K 0.12%
3,942
-251
-6% -$12.3K
KEYS icon
199
Keysight
KEYS
$54.5B
$203K 0.12%
1,215
-105
-8% -$16.3K
SWK icon
200
Stanley Black & Decker
SWK
$14.3B
$203K 0.12%
+2,169
New +$180K
6 7
8
9 10

Similar funds

MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
NCM
Northwest Capital Management Lake Oswego, Oregon $23.1M AUM 13.6% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $23.7M AUM
PIM
Profit Investment Management North Bethesda, Maryland $24.7M AUM 21.29% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM
SWM
Stark Wealth Management Bethlehem, Pennsylvania $26.6M AUM 23.19% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return

Vantage Consulting Group's Q2 2023 Portfolio in Review

As of Q2 2023, Vantage Consulting Group held 237 positions worth $174M, down 1.3% from $176M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Vantage Consulting Group deployed $10.4M of net new capital in Q2 2023, opening 6 new positions and adding to 44 existing holdings. Its largest new stake was Cibus: 1,262,842 shares worth $13.3M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Royalty Pharma, an estimated $12.6M trimmed.

  • Vantage Consulting Group's largest Q2 2023 buy was Cibus: 1,262,842 shares worth $13.3M.
  • Vantage Consulting Group added most to Comerica in Q2 2023, an estimated $237K increase.
  • Vantage Consulting Group's biggest Q2 2023 reduction was Royalty Pharma, cutting an estimated $12.6M.
  • Vantage Consulting Group fully exited General Mills in Q2 2023, selling an estimated $237K.
  • Vantage Consulting Group's ten largest holdings make up 63% of its $174M portfolio in Q2 2023.
  • Vantage Consulting Group opened 6 new positions and closed 21 in Q2 2023.
  • Vantage Consulting Group's portfolio value fell 1.3% quarter-over-quarter to $174M.

Based on Vantage Consulting Group's 13F filing for Q2 2023, filed 11 Aug 2023.